北京同仁堂磷虾油涉嫌造假将被约谈

Recently, online rumors claimed that ‘Beijing Tongrentang’s krill oil is suspected of being counterfeit and the company will be summoned by regulators,’ sparking public concern. In response, Beijing Tongrentang promptly clarified that its products strictly comply with national standards for pharmaceuticals and health supplements, with all ingredients sourced from approved suppliers and subjected to multiple quality tests. The company emphasized that it has not received any official notice of a regulatory summons and that the allegations of ‘counterfeiting’ lack factual basis—likely stemming from misunderstandings about product labeling or ingredients.Krill oil, a dietary supplement rich in omega-3 fatty acids (EPA and DHA) and the natural antioxidant astaxanthin, has gained popularity among health-conscious consumers in recent years. As a time-honored Chinese brand with over 300 years of history, Tongrentang has long prioritized quality and integrity in its health products. Experts advise consumers to purchase such supplements only through authorized channels, verify product registration details, and approach online rumors with caution.As of now, neither China’s State Administration for Market Regulation nor the Beijing Municipal Drug Administration has issued an official statement on the matter. Tongrentang stated it remains committed to full regulatory compliance, consumer protection, and reserves the right to take legal action against the spread of false information.

近日,有网络传言称‘北京同仁堂磷虾油涉嫌造假,将被监管部门约谈’,引发公众关注。对此,北京同仁堂方面迅速回应,表示相关产品严格遵循国家药品和保健品生产标准,所有原料均来自合规渠道,并已通过多项质量检测。公司强调,目前未收到任何官方监管部门的约谈通知,所谓‘造假’说法缺乏事实依据,可能是对产品成分或标签信息的误解。磷虾油作为一种富含Omega-3脂肪酸(EPA和DHA)及天然抗氧化剂虾青素的营养补充剂,近年来受到消费者青睐。同仁堂作为拥有三百多年历史的中华老字号,在保健品领域一直注重品质与信誉。专家提醒,消费者在选购此类产品时,应认准正规渠道、查看产品备案信息,并理性看待网络传言。截至目前,国家市场监督管理总局及北京市药监局尚未就此事发布正式通报。同仁堂表示将持续配合监管要求,保障消费者权益,并保留对不实信息追责的权利。

原创文章,作者:admin,如若转载,请注明出处:https://avine.cn/4170.html

(0)
上一篇 2025年12月15日 上午8:02
下一篇 2025年12月15日 上午8:03

相关推荐